81 related articles for article (PubMed ID: 10515820)
1. Colonic epithelial physiology is altered in response to the bacterial superantigen Yersinia pseudotuberculosis mitogen.
Donnelly GA; Lu J; Takeda T; McKay DM
J Infect Dis; 1999 Nov; 180(5):1590-6. PubMed ID: 10515820
[TBL] [Abstract][Full Text] [Related]
2. Superantigen activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via IFN-gamma and TNF alpha: inhibition of increased permeability, but not diminished secretory responses by TGF-beta2.
McKay DM; Singh PK
J Immunol; 1997 Sep; 159(5):2382-90. PubMed ID: 9278329
[TBL] [Abstract][Full Text] [Related]
3. Epithelial ion transport and barrier abnormalities evoked by superantigen-activated immune cells are inhibited by interleukin-10 but not interleukin-4.
Lu J; Philpott DJ; Saunders PR; Perdue MH; Yang PC; McKay DM
J Pharmacol Exp Ther; 1998 Oct; 287(1):128-36. PubMed ID: 9765331
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide reduces bacterial superantigen-immune cell activation and consequent epithelial abnormalities.
Rachlis A; Watson JL; Lu J; McKay DM
J Leukoc Biol; 2002 Aug; 72(2):339-46. PubMed ID: 12149425
[TBL] [Abstract][Full Text] [Related]
5. Critical role of T cell migration in bacterial superantigen-mediated shock in mice.
Kano H; Ito Y; Matsuoka K; Nakajima T; Iwata T; Kohsaka T; Saito H; Abe J
Clin Immunol; 2004 Feb; 110(2):159-71. PubMed ID: 15003813
[TBL] [Abstract][Full Text] [Related]
6. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms.
Uchiyama T; Miyoshi-Akiyama T; Kato H; Fujimaki W; Imanishi K; Yan XJ
J Immunol; 1993 Oct; 151(8):4407-13. PubMed ID: 8409410
[TBL] [Abstract][Full Text] [Related]
7. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM.
Miyoshi-Akiyama T; Abe A; Kato H; Kawahara K; Narimatsu H; Uchiyama T
J Immunol; 1995 May; 154(10):5228-34. PubMed ID: 7730627
[TBL] [Abstract][Full Text] [Related]
8. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein.
Ito Y; Abe J; Yoshino K; Takeda T; Kohsaka T
J Immunol; 1995 Jun; 154(11):5896-906. PubMed ID: 7751634
[TBL] [Abstract][Full Text] [Related]
9. Generated single point-mutations can considerably dismantle the lymphocyte overstimulation induced by Yersinia pseudotuberculosis superantigen.
Seprényi G; Ito Y; Kohsaka T
Cell Immunol; 1999 Mar; 192(2):96-106. PubMed ID: 10087177
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the superantigen-producing ability of Yersinia pseudotuberculosis strains of various serotypes isolated from patients with systemic or gastroenteric infections, wildlife animals and natural environments.
Ueshiba H; Kato H; Miyoshi-Akiyama T; Tsubokura M; Nagano T; Kaneko S; Uchiyama T
Zentralbl Bakteriol; 1998 Oct; 288(2):277-91. PubMed ID: 9809408
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosis.
Yoshino K; Abe J; Murata H; Takao T; Kohsaka T; Shimonishi Y; Takeda T
FEBS Lett; 1994 Dec; 356(1):141-4. PubMed ID: 7988709
[TBL] [Abstract][Full Text] [Related]
12. Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells.
Goubard A; Loïez C; Abe J; Fichel C; Herwegh S; Faveeuw C; Porte R; Cayet D; Sebbane F; Penet S; Foligné B; Desreumaux P; Saito H; Sirard JC; Simonet M; Carnoy C
Infect Immun; 2015 May; 83(5):2053-64. PubMed ID: 25754199
[TBL] [Abstract][Full Text] [Related]
13. Identification of the functional region on the superantigen Yersinia pseudotuberculosis-derived mitogen responsible for induction of lymphocyte proliferation by using synthetic peptides.
Yoshino K; Takao T; Ishibashi M; Samejima Y; Shimonishi Y; Takeda T
FEBS Lett; 1996 Jul; 390(2):196-8. PubMed ID: 8706858
[TBL] [Abstract][Full Text] [Related]
14. Evidence for superantigen production by Yersinia pseudotuberculosis.
Abe J; Takeda T; Watanabe Y; Nakao H; Kobayashi N; Leung DY; Kohsaka T
J Immunol; 1993 Oct; 151(8):4183-8. PubMed ID: 8409395
[TBL] [Abstract][Full Text] [Related]
15. Continuous exposure of mice to superantigenic toxins induces a high-level protracted expansion and an immunological memory in the toxin-reactive CD4+ T cells.
Chen L; Koyanagi M; Fukada K; Imanishi K; Yagi J; Kato H; Miyoshi-Akiyama T; Zhang R; Miwa K; Uchiyama T
J Immunol; 2002 Apr; 168(8):3817-24. PubMed ID: 11937534
[TBL] [Abstract][Full Text] [Related]
16. Clinical role for a superantigen in Yersinia pseudotuberculosis infection.
Abe J; Onimaru M; Matsumoto S; Noma S; Baba K; Ito Y; Kohsaka T; Takeda T
J Clin Invest; 1997 Apr; 99(8):1823-30. PubMed ID: 9109426
[TBL] [Abstract][Full Text] [Related]
17. Identification of murine T cells reactive with the bacterial superantigen Yersinia pseudotuberculosis-derived mitogen (YPM) and factors involved in YPM-induced toxicity in mice.
Miyoshi-Akiyama T; Fujimaki W; Yan XJ; Yagi J; Imanishi K; Kato H; Tomonari K; Uchiyama T
Microbiol Immunol; 1997; 41(4):345-52. PubMed ID: 9159409
[TBL] [Abstract][Full Text] [Related]
18. The superantigenic toxin of Yersinia pseudotuberculosis: a novel virulence factor?
Carnoy C; Müller-Alouf H; Desreumaux P; Mullet C; Grangette C; Simonet M
Int J Med Microbiol; 2000 Oct; 290(4-5):477-82. PubMed ID: 11111929
[TBL] [Abstract][Full Text] [Related]
19. Purification and gene cloning of a superantigen (YPM) produced by a patient strain of Yersinia pseudotuberculosis.
Takeda T; Yoshino K; Itoh Y; Abe J; Shimonishi Y; Kohsaka T
Contrib Microbiol Immunol; 1995; 13():331-3. PubMed ID: 8833866
[No Abstract] [Full Text] [Related]
20. Geographical heterogeneity between Far East and Europe in prevalence of ypm gene encoding the novel superantigen among Yersinia pseudotuberculosis strains.
Yoshino K; Ramamurthy T; Nair GB; Fukushima H; Ohtomo Y; Takeda N; Kaneko S; Takeda T
J Clin Microbiol; 1995 Dec; 33(12):3356-8. PubMed ID: 8586739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
